CLOs on the Move


 
Humans across the globe and of all walks of life want to live at their personal best, and are seeking more natural alternatives to feeling their best and getting the most out of life. Today, they are discovering the answer through natural cannabinoid products. At the same time, science and technology are unlocking the future potential of cannabinoids. We believe that cannabinoids, when used responsibly, have the power to enhance the full spectrum of well-being and to help us live healthier and happier lives. Parallel is improving the well-being of our consumers today through our proprietary, innovative ...
  • Number of Employees: 1K-5K
  • Annual Revenue: $10-50 Million
  • www.liveparallel.com
  • 55 Ivan Allen Junior Boulevard North West Suite 900
    Atlanta, GA USA 30308
  • Phone: N/A

Executives

Name Title Contact Details
Charles Huntsinger
Director Of Compliance Profile
Lauren Linder
Deputy General Counsel Profile

Similar Companies

Legacy Good Samaritan Hospital and Medical Center

Legacy Good Samaritan Hospital & Medical Center is a Portland, OR-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

KPR

KPR is a Granada Hills, CA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Cell Point LLC

Cell Point LLC is one of the leading providers in Healthcare, Pharmaceuticals, & Biotech. It is based in Centennial, CO. To find more information about Cell Point LLC, please visit www.cellpointweb.com

CardioMEMS

CardioMEMS is a medical device company that has developed and is commercializing a proprietary wireless sensing and communication technology for the human body. Our technology platform is designed to improve the management of severe chronic cardiovascular diseases such as heart failure and aneurysms. Our miniature wireless sensors can be implanted using minimally invasive techniques and transmit cardiac output, blood pressure and heart rate data that are critical to the management of patients. Due to their small size, durability, and lack of wires and batteries, our sensors are designed to be permanently implanted into the cardiovascular system. Using radiofrequency, or RF, energy, our sensors transmit real-time data to an external electronics module, which then communicates this information to the patient’s physician.

Sarah Cannon Research Institute

SCRI, an industry leader in clinical trials, is dedicated to advancing therapies for patients through clinical research.